Petersen M B, Friis C
Department of Pharmacology and Pathobiology, Royal Veterinary and Agricultural University, Copenhagen, Denmark.
Am J Vet Res. 2000 May;61(5):573-6. doi: 10.2460/ajvr.2000.61.573.
To determine pharmacokinetics and metabolic patterns of fenbendazole after IV and oral administration to pigs.
4 mixed-breed female pigs weighing 32 to 45 kg.
Fenbendazole was administered IV at a dose of 1 mg/kg. One week later, it was administered orally at a dose of 5 mg/kg. Blood samples were collected for up to 72 hours after administration, and plasma concentrations of fenbendazole, oxfendazole, and fenbendazole sulfone were determined by use of high-pressure liquid chromatography. Plasma pharmacokinetics were determined by use of noncompartmental methods.
Body clearance of fenbendazole after IV administration was 1.36 L/h/kg, volume of distribution at steady state was 3.35 L/kg, and mean residence time was 2.63 hours. After oral administration, peak plasma concentration of fenbendazole was 0.07 microg/ml, time to peak plasma concentration was 3.75 hours, and mean residence time was 15.15 hours. Bioavailability of fenbendazole was 27.1%. Oxfendazole was the major plasma metabolite, accounting for two-thirds of the total area under the plasma concentration versus time curve after IV and oral administration. Fenbendazole accounted for 8.4% of the total AUC after IV administration and 4.5% after oral administration.
Results indicate that fenbendazole was rapidly eliminated from plasma of pigs. The drug was rapidly absorbed after oral administration, but systemic bioavailability was low.
确定芬苯达唑静脉注射和口服给药后在猪体内的药代动力学及代谢模式。
4头体重32至45千克的混种雌性猪。
芬苯达唑以1毫克/千克的剂量静脉注射。一周后,以5毫克/千克的剂量口服给药。给药后长达72小时采集血样,采用高压液相色谱法测定血浆中芬苯达唑、奥芬达唑和芬苯达唑砜的浓度。采用非房室模型方法确定血浆药代动力学。
静脉注射后芬苯达唑的体内清除率为1.36升/小时/千克,稳态分布容积为3.35升/千克,平均驻留时间为2.63小时。口服给药后,芬苯达唑的血浆峰浓度为0.07微克/毫升,达峰时间为3.75小时,平均驻留时间为15.15小时。芬苯达唑的生物利用度为27.1%。奥芬达唑是主要的血浆代谢产物,静脉注射和口服给药后,其在血浆浓度-时间曲线下的总面积占三分之二。静脉注射后芬苯达唑占总药时曲线下面积的8.4%,口服给药后占4.5%。
结果表明芬苯达唑能迅速从猪血浆中消除。该药物口服后吸收迅速,但全身生物利用度较低。